{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:33:33Z","timestamp":1791333213075,"version":"4.3.1"},"reference-count":37,"publisher":"Impact Journals, LLC","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2017,1,24]]},"DOI":"10.18632\/oncotarget.13362","type":"journal-article","created":{"date-parts":[[2016,11,15]],"date-time":"2016-11-15T22:40:58Z","timestamp":1479249658000},"page":"5992-6002","source":"Crossref","is-referenced-by-count":54,"title":["RICTOR amplification identifies a subgroup in small cell lung cancer and predicts response to drugs targeting mTOR"],"prefix":"10.18632","volume":"8","author":[{"given":"Nneha","family":"Sakre","sequence":"first","affiliation":[{"name":"Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland, Ohio, 44106 USA"},{"name":"Division of Hematology and Oncology, University Hospitals Cleveland Medical Center, Cleveland, Ohio, 44106 USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary","family":"Wildey","sequence":"additional","affiliation":[{"name":"Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland, Ohio, 44106 USA"},{"name":"Division of Hematology and Oncology, University Hospitals Cleveland Medical Center, Cleveland, Ohio, 44106 USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohadese","family":"Behtaj","sequence":"additional","affiliation":[{"name":"Department of Pathology, University Hospitals Cleveland Medical Center, Cleveland, Ohio, 44106 USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Kresak","sequence":"additional","affiliation":[{"name":"Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland, Ohio, 44106 USA"},{"name":"Department of Pathology, University Hospitals Cleveland Medical Center, Cleveland, Ohio, 44106 USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Pathology, University Hospitals Cleveland Medical Center, Cleveland, Ohio, 44106 USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pingfu","family":"Fu","sequence":"additional","affiliation":[{"name":"Epidemiology and Biostatistics, Case Western Reserve University, Cleveland, Ohio, 44106 USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Afshin","family":"Dowlati","sequence":"additional","affiliation":[{"name":"Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland, Ohio, 44106 USA"},{"name":"Division of Hematology and Oncology, University Hospitals Cleveland Medical Center, Cleveland, Ohio, 44106 USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2016,11,15]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"4539","DOI":"10.1200\/JCO.2005.04.4859","article-title":"Changing epidemiology of small-cell lung cancer in the United States over the last 30 years: analysis of the surveillance, epidemiologic, and end results database","volume":"24","author":"Piccirillo","year":"2006","journal-title":"J Clin Oncol"},{"key":"2","first-page":"533","article-title":"Novel therapies in small cell lung cancer","volume":"4","author":"Jalal","year":"2015","journal-title":"Transl Lung Cancer Res"},{"key":"3","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1038\/ng.2405","article-title":"Comprehensive genomic analysis identifies SOX2 as a frequently amplified gene in small-cell lung cancer","volume":"44","author":"Bhatt","year":"2012","journal-title":"Nature genetics"},{"key":"4","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1038\/ng.2396","article-title":"Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer","volume":"44","author":"Dahmen","year":"2012","journal-title":"Nature genetics"},{"key":"5","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/nature14664","article-title":"Comprehensive genomic profiles of small cell lung cancer","volume":"524","author":"Jahchan","year":"2015","journal-title":"Nature"},{"key":"6","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1093\/annonc\/mdw005","article-title":"Clinical correlation of extensive-stage small-cell lung cancer genomics","volume":"27","author":"Wildey","year":"2016","journal-title":"Annals of oncology"},{"key":"7","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1172\/JCI44145","article-title":"Next-generation mTOR inhibitors in clinical oncology: how pathway complexity informs therapeutic strategy","volume":"121","author":"Slingerland","year":"2011","journal-title":"The Journal of clinical investigation"},{"key":"8","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1242\/jcs.095299","article-title":"TGF-beta-induced activation of mTOR complex 2 drives epithelial-mesenchymal transition and cell invasion","volume":"125","author":"Derynck","year":"2012","journal-title":"J Cell Sci"},{"key":"9","doi-asserted-by":"crossref","first-page":"3246","DOI":"10.1158\/0008-5472.CAN-10-4058","article-title":"mTORC1 and mTORC2 regulate EMT, motility, and metastasis of colorectal cancer via RhoA and Rac1 signaling pathways","volume":"71","author":"Evers","year":"2011","journal-title":"Cancer research"},{"key":"10","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1007\/s10549-012-2036-2","article-title":"Targeting of mTORC2 prevents cell migration and promotes apoptosis in breast cancer","volume":"134","author":"Bai","year":"2012","journal-title":"Breast Cancer Res Treat"},{"key":"11","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1038\/nbt.2696","article-title":"Development and validation of a clinical cancer genomic profiling test based on massively parallel DNA sequnecing","volume":"31","author":"Brennan","year":"2013","journal-title":"Nature biotechnol"},{"key":"12","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/nature11003","article-title":"The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity","volume":"483","author":"Murray","year":"2012","journal-title":"Nature"},{"key":"13","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1093\/hmg\/ddp034","article-title":"The SRY-HMG box gene, SOX4, is a target of gene amplification at chromosome 6p in lung cancer","volume":"18","author":"Sanchez-Cespedes","year":"2009","journal-title":"Human molecular genetics"},{"key":"14","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1136\/thoraxjnl-2013-204681","article-title":"Invited review DNA copy number changes as diagnostic tools for lung cancer","volume":"69","author":"Bowcock","year":"2014","journal-title":"Thorax"},{"key":"15","first-page":"16224","article-title":"Integrated analysis of homozygous deletions, focal amplifications, and sequence alterations in breast and colorectal cancers","volume":"105","author":"Willson","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"16","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.ygyno.2014.09.014","article-title":"Somatic copy number alterations predict response to platinum therapy in epithelial ovarian cancer","volume":"135","author":"Lambrechts","year":"2014","journal-title":"Gynecologic oncology"},{"key":"17","doi-asserted-by":"crossref","first-page":"247","DOI":"10.7150\/jca.10747","article-title":"Non-invasive Analysis of Genomic Copy Number Variation in Patients with Hepatocellular Carcinoma by Next Generation DNA Sequencing","volume":"6","author":"Zhu","year":"2015","journal-title":"Journal of Cancer"},{"key":"18","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1186\/s13023-014-0181-x","article-title":"Genomic screening of testicular germ cell tumors from monozygotic twins","volume":"9","author":"Rogatto","year":"2014","journal-title":"Orphanet journal of rare diseases"},{"key":"19","doi-asserted-by":"crossref","first-page":"E578","DOI":"10.1002\/ijc.29215","article-title":"Genome-wide CNV analysis in 221 unrelated patients and targeted high-throughput sequencing reveal novel causative candidate genes for colorectal adenomatous polyposis","volume":"136","author":"Adam","year":"2015","journal-title":"International journal of cancer"},{"key":"20","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1186\/1471-2407-14-854","article-title":"Chromosomal alterations in exfoliated urothelial cells from bladder cancer cases and healthy men: a prospective screening study","volume":"14","author":"Stenzl","year":"2014","journal-title":"BMC cancer"},{"key":"21","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.gene.2014.10.021","article-title":"Copy number loss or silencing of apoptosis-effector genes in cancer","volume":"554","author":"Blanck","year":"2015","journal-title":"Gene"},{"key":"22","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s13402-013-0162-4","article-title":"High-level copy number gains of established and potential drug target genes in gastric cancer as a lead for treatment development and selection","volume":"37","author":"Meijer","year":"2014","journal-title":"Cellular oncology"},{"key":"23","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1136\/jclinpath-2014-202447","article-title":"Next-generation sequencing reveals frequent consistent genomic alterations in small cell undifferentiated lung cancer","volume":"67","author":"Elvin","year":"2014","journal-title":"J Clin Pathol"},{"key":"24","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1097\/JTO.0000000000000250","article-title":"Therapeutic priority of the PI3K\/AKT\/mTOR pathway in small cell lung cancers as revealed by a comprehensive genomic analysis","volume":"9","author":"Ochiai","year":"2014","journal-title":"J Thorac Oncol"},{"key":"25","doi-asserted-by":"crossref","first-page":"3733","DOI":"10.1038\/onc.2010.139","article-title":"Targeting mTOR: prospects for mTOR complex 2 inhibitors in cancer therapy","volume":"29","author":"Guertin","year":"2010","journal-title":"Oncogene"},{"key":"26","doi-asserted-by":"crossref","first-page":"2995","DOI":"10.2174\/092986711796391651","article-title":"ATP-competitive inhibitors of mTOR: an update","volume":"18","author":"Botta","year":"2011","journal-title":"Current medicinal chemistry"},{"key":"27","doi-asserted-by":"crossref","first-page":"e0131400","DOI":"10.1371\/journal.pone.0131400","article-title":"Potentiation of Growth Inhibitory Responses of the mTOR Inhibitor Everolimus by Dual mTORC1\/2 Inhibitors in Cultured Breast Cancer Cell Lines","volume":"10","author":"Baguley","year":"2015","journal-title":"PloS one"},{"key":"28","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1111\/bjh.12945","article-title":"Time now to TORC the TORC? New developments in mTOR pathway inhibition in lymphoid malignancies","volume":"166","author":"Cwynarski","year":"2014","journal-title":"British journal of haematology"},{"key":"29","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1158\/2159-8290.CD-14-0971","article-title":"RICTOR Amplification Defines a Novel Subset of Patients with Lung Cancer Who May Benefit from Treatment with mTORC1\/2 Inhibitors","volume":"5","author":"Schwartz","year":"2015","journal-title":"Cancer discovery"},{"key":"30","doi-asserted-by":"crossref","unstructured":"Pike, Malagu, Hummersone, Menear, Duggan, Gomez, Martin, Ruston, Pass, Pass. Optimization of potent and selective dual mTORC1 and mTORC2 inhibitors: the discovery of AZD8055 and AZD2014. Bioorganic & medicinal chemistry letters. 2013; 23:1212\u20131216.","DOI":"10.1016\/j.bmcl.2013.01.019"},{"key":"31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4161\/cbt.10.1.12045","article-title":"The molecular pathogenesis of small cell lung cancer","volume":"10","author":"Pietanza","year":"2010","journal-title":"Cancer biology & therapy"},{"key":"32","article-title":"Transforming Growth Factor-beta Is an Upstream Regulator of Mammalian Target of Rapamycin Complex 2-Dependent Bladder Cancer Cell Migration and Invasion","author":"Hansel","year":"2016","journal-title":"The American journal of pathology"},{"key":"33","doi-asserted-by":"crossref","first-page":"4507","DOI":"10.1007\/s11033-014-3321-4","article-title":"Inhibition of mTOR pathway attenuates migration and invasion of gallbladder cancer via EMT inhibition","volume":"41","author":"Xiang","year":"2014","journal-title":"Molecular biology reports"},{"key":"34","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1186\/1471-2407-14-855","article-title":"Prognostic and diagnostic value of epithelial to mesenchymal transition markers in pulmonary neuroendocrine tumors","volume":"14","author":"Gonzalez","year":"2014","journal-title":"BMC cancer"},{"key":"35","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1158\/1078-0432.CCR-13-1330","article-title":"Targeting epithelial-to-mesenchymal transition with Met inhibitors reverts chemoresistance in small cell lung cancer","volume":"20","author":"Rovira","year":"2014","journal-title":"Clin Cancer Res"},{"key":"36","first-page":"14676","article-title":"Expression of molecular factors correlated with metastasis in small cell lung cancer and their significance","volume":"8","author":"Wang","year":"2015","journal-title":"Int J Clin Exp Pathol"},{"key":"37","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1097\/JTO.0000000000000176","article-title":"RET mutation and expression in small-cell lung cancer","volume":"9","author":"Dowlati","year":"2014","journal-title":"J Thorac Oncol"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.13362","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,6]],"date-time":"2020-08-06T13:46:28Z","timestamp":1596721588000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.13362"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11,15]]},"references-count":37,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,1,24]]}},"alternative-id":["13362","27863413"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.13362","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11,15]]}}}